Literature DB >> 8180197

The mutant Escherichia coli F112W cyclophilin binds cyclosporin A in nearly identical conformation as human cyclophilin.

J Fejzo1, F A Etzkorn, R T Clubb, Y Shi, C T Walsh, G Wagner.   

Abstract

The periplasmic Escherichia coli cyclophilin is distantly related to human cyclophilin (34% sequence identity). Peptidyl-prolyl isomerase activity, cyclosporin A binding, and inhibition of the calcium-dependent phosphatase calcineurin are compared for human and E. coli wild-type and mutant proteins. Like human cyclophilin, the E. coli protein is a cis-trans peptidyl-prolyl isomerase. However, while the human protein binds cyclosporin A tightly (Kd = 17 nM), the E. coli protein does not (Kd = 3.4 microM). The mutant F112W E. coli cyclophilin has enhanced cyclosporin binding (Kd = 170 nM). As for the human protein, the complex of the E. coli mutant with cyclosporin A inhibits calcineurin. Here we describe the structure at pH 6.2 of cyclosporin A bound to the mutant E. coli cyclophilin as solved with solution NMR methods. Despite the low overall sequence identity, the structure of the bound cyclosporin A is virtually identical in both proteins. To assess differences of the cyclosporin binding site, the solution structure of wild-type E. coli cyclophilin was compared with structures of uncomplexed human cyclophilin A and with cyclosporin bound. Despite the structural similarity of bound cyclosporin A, the architecture of the binding site in the E. coli protein is substantially different at the site most distant to tryptophan 121 (human sequence). This site is constructed by a five-residue insertion in a loop of the E. coli protein, replacing another loop in the human protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180197     DOI: 10.1021/bi00185a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Functional glycan-free adhesion domain of human cell surface receptor CD58: design, production and NMR studies.

Authors:  Z Y Sun; V Dötsch; M Kim; J Li; E L Reinherz; G Wagner
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

2.  Structure of cyclophilin from Leishmania donovani at 1.97 A resolution.

Authors:  V Venugopal; Banibrata Sen; Alok K Datta; Rahul Banerjee
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-01-17

3.  Cyclosporin A: Conformational Complexity and Chameleonicity.

Authors:  Satoshi Ono; Matthew R Naylor; Chad E Townsend; Chieko Okumura; Okimasa Okada; Hsiau-Wei Lee; R Scott Lokey
Journal:  J Chem Inf Model       Date:  2021-10-21       Impact factor: 6.162

4.  Structural, biochemical, and in vivo characterization of the first virally encoded cyclophilin from the Mimivirus.

Authors:  Vu Thai; Patricia Renesto; C Andrew Fowler; Darin J Brown; Tara Davis; Wanjun Gu; David D Pollock; Dorothee Kern; Didier Raoult; Elan Z Eisenmesser
Journal:  J Mol Biol       Date:  2007-08-29       Impact factor: 5.469

5.  Isoform-specific inhibition of cyclophilins.

Authors:  Sebastian Daum; Michael Schumann; Sebastian Mathea; Tobias Aumüller; Molly A Balsley; Stephanie L Constant; Boris Féaux de Lacroix; Fabian Kruska; Manfred Braun; Cordelia Schiene-Fischer
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.